InflaRx Showcases Vilobelimab’s Role in Immuno-Dermatology at the 2025 AAD Annual Meeting
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced the presentation of multiple posters describing the ...
hometownsource.com4d
Til Dysfunction Do Us Part: The Dinner Party brings marital mayhem to Spring Grove
A mix of quick wit, deep reflection, and comedic tension is coming to Spring Grove’s Ye Olde Opera House’s stage, as actors ...
InflaRx (NASDAQ:IFRX) Receives Buy Rating from HC Wainwright
HC Wainwright restated their buy rating on shares of InflaRx (NASDAQ:IFRX – Free Report) in a report published on Friday morning,Benzinga reports. HC Wainwright currently has a $8.00 price target on ...
99.co4d
The Arcady At Boon Keng
Ample transportation options nearby ~ Located within a short walk from Boon Keng MRT station on the North East Line (NEL). Excellent school options in the area ~ There are plenty of schools nearby ...